Two single-dose studies were conducted in Japan and Europe to compare the pharmacokinetic ( PK ) and pharmacodynamic ( PD ) profiles of new insulin glargine @U/ml ( Gla-@ ) and insulin glargine @U/ml ( Gla-@ ) in people with type @ diabetes mellitus .